Sutro Biopharma

IPO

Sutro Biopharma, Inc. is a public biotechnology company focused on clinical stage drug discovery, development and manufacturing company.

Public · South San Francisco, United States · Founded 2003 · $168.9M raised

Employees
201–500
Founded
2003
Business Model
B2B
Total Funding
$168.9M
Last Round
$85.4M Series EJul 2018
Rounds
5
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Sutro Biopharma is a clinical-stage oncology company pioneering site-specific and novel-format antibody-drug conjugates (ADCs) built on its proprietary XpressCF cell-free protein synthesis and XpressCF+ conjugation platforms. Headquartered in South San Francisco, Sutro develops ADCs, bispecific antibodies, cytokine-based immuno-oncology therapies, and vaccines for cancers with unmet need, including STRO-001 and STRO-002 (luvelta), and collaborates with partners such as Merck and Astellas Pharma on additional programs.

Summary

Sutro Biopharma is a Biotech company based in South San Francisco, United States, founded in 2003. It has raised $168.9M in total across 5 rounds, most recently a $85.4M Series E round in Jul 2018. Investors include SV Health Investors, Samsara BioCapital and Surveyor Capital.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Secondary MarketSecondary MarketFeb 2026

Sign up to see all 9 events

Funding: Grant through Series E. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sutro Biopharma on Indexed.vc
<a href="https://indexed.vc/companies/sutro-biopharma"><img src="https://indexed.vc/api/badge/company/sutro-biopharma" alt="Sutro Biopharma on Indexed.vc" width="260" height="76" /></a>